SWISS BRIDGE AWARD 2024
Type: R
Deadline: April 30 2024 (LOI); Mid June (FP)
Swiss Bridge is a private foundation with the purpose to seek support for cancer research. Since 2000, the Swiss Bridge Award has been granted to support high-quality cancer research projects in Europe. This year, young investigators with projects focusing on cancer therapy resistance are eligible for application.
Recipient: early-stage researchers under the age of 45 holding a PhD or MD and having obtained an independent position at a hospital, university, or research institute in Europe (e.g. junior group leaders, assistant professors, lecturers, scientists establishing their own research group).
Budget: top-ranked projects will receive funding amounting to a total support of 500.000 Swiss francs.